Navigation Links
Duragesic Trials Continue - Plaintiffs Optimistic After Latest Recall

Lawyer who brought the first federal case against J&J prepares for next


LOS ANGELES, Feb. 13 /PRNewswire/ -- In the wake of Tuesday's Duragesic recall of over 2 million patches, lawyer Ike Gulas prepares to take the next major case against pharmaceutical giant Johnson and Johnson to trial in California State Court Southeast District in Los Angeles.

The Birmingham, Ala.-based law firm Gulas & Stuckey PC took the first Duragesic case to federal trial in West Palm Beach in June 2007, winning a $5.5 million verdict for the family of Adam Hendelson who died from an overdose of the drug fentanyl when the patch he wore due to chronic hip pain leaked.

The family of Carol Pinedo will be the second of Gulas & Stuckey's clients to face Johnson & Johnson subsidiaries Janssen Pharmaceutica Products, LP, and ALZA Corp. in court over death resulting from the company's pain patch Duragesic.

Pinedo died in April 2004, the same month Janssen issued a recall of about 2.2 million patches after determining that some might leak along one edge. She was 39 at the time and had been wearing a Duragesic patch for 6 months as treatment for severe migraines following the removal of benign brain tumors.

Pinedo's husband Joseph, has brought the suit forward to Gulas & Stuckey after his wife's death. Joseph is a custodian for the Los Angeles school system with four children: Jessie Marie, Michelle, Christine and Natalie Angela.

"The manufacturers of this drug should be held accountable," said Ike Gulas. "This recent recall reaffirms the fact that this drug is lethal and is responsible for many unnecessary deaths, as in the case of Carol Pinedo."

More than 100 cases have been filed nationwide involving Duragesic. Gulas & Stuckey will take the Pinedo case to trial sometime later this year.

For more information about Duragesic and about Gulas & Stuckey, P.C., go to

SOURCE Gulas & Stuckey, P.C.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. PriCara(TM) Recalls 25 mcg/hr DURAGESIC(R) (fentanyl transdermal system) CII Pain Patches
2. Study Questions Dead-End Cancer Clinical Trials
3. Clinical trials present better alternatives for dialysis patients
4. IMPACT initiative looks to improve patient participation in clinical trials
5. Clinical Trials Directive still hampering academic medical research
6. Oncolytics Biotech Inc. reports positive interim results of UK phase Ia/Ib trials
7. American Pacific Management to Present at CIBC World Markets 2nd Industrials Conference
8. Clinical Trials for Lupus Underway After Decades of Drought
9. Paving the way for future pan-European clinical trials
10. GenPrime Initiates External Clinical Trials of its Bacterial Contamination Test for Rapid Detection of Bacteria in Platelets
11. Rutgers biomaterial debuts in clinical trials of new stent
Post Your Comments:
(Date:11/29/2015)... , ... November 29, 2015 , ... Effective immediately, every ... In addition starting on Black Friday Target is offering a “Buy One Scrub Set, ... is a rare opportunity to purchase IguanaMed at a discounted price. , ...
(Date:11/28/2015)... ... 2015 , ... Safe storage for contraceptive devices may not always be easy ... Jersey and the other from Bradley Beach, New Jersey, there is an easy solution ... having to replace NuvaRings more often than necessary. As such, it affords peace of ...
(Date:11/28/2015)... ... November 28, 2015 , ... Pixel Film Studios is back ... to choose from, the possibilities are endless. Users have full control over angle of ... Pulse masking effects, users are sure to get heads to turn. , ProPanel: Pulse ...
(Date:11/27/2015)... Angeles, CA (PRWEB) , ... November 27, 2015 , ... ... study carried out by the University of Toronto and the University of British Columbia ... of hospitalizations for head injuries. The article explains that part of the reason for ...
(Date:11/27/2015)... ... ... A team of Swiss doctors has released a report on mesothelioma relapse ... the findings on the website. Click here to read the details now. ... who were treated with chemotherapy followed by EPP surgery. Among the 106 patients who ...
Breaking Medicine News(10 mins):
(Date:11/27/2015)... DUBLIN , Nov. 26, 2015 /PRNewswire/ ... announced the addition of the "2016 ... by Test, Country Volume and Sales Segment ... Emerging Opportunities" report to their offering. ... the addition of the "2016 Global ...
(Date:11/26/2015)... , 26 november 2015 ... kondigt de geplande investering aan van ten ... de laboratoria en het mondiale hoofdkantoor in ... uitbreiding zal resulteren in extra kantoorruimte en ... aan de groeiende behoeften van de farmaceutische ...
(Date:11/26/2015)... --> --> Juntendo University ... contrast weighting of MRI for patients with Multiple Sclerosis ... agreement with SyntheticMR in order to use SyMRI in clinical ... to generate multiple contrast images from a single scan and ... making it possible to both fine tune images and recreate ...
Breaking Medicine Technology: